Comparing a new wound dressing for diabetic foot ulcers to standard care
Official title: A Pilot Open Label Prospective, Randomised, Study to Evaluate the Safety and Efficacy of Keneric Healthcare RTD Wound Dressing in the Treatment of Diabetic Foot Ulcers Compared to Standard of Care
Run by Community Pharmacology Services Ltd · NCT05762432 · Data updated 2026-11-12
This study is testing a new wound dressing for diabetic foot ulcers to see if it works better than the usual treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Community Pharmacology Services Ltd Academic / other |
| Locations | 2 sites (Airdrie, North Lanarkshire and 1 other locations) |
| Status | Recruiting |
| Started | April 26, 2024 |
| Main results expected | December 1, 2026 |
| Study ends | January 1, 2027 |
| Registry record updated | January 26, 2026 |
| Trial ID | NCT05762432 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 and older with type 1 or type 2 diabetes who have a new presentation of a non-infected diabetic foot ulcer.
✕Probably not a fit
Patients with known allergies to the study dressing, critical limb ischaemia, or those who are pregnant or breastfeeding may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the safety and effectiveness of the RTD Wound Dressing in treating non-infected neuropathic, ischaemic, and neuro-ischaemic diabetic foot ulcers compared to the current standard of care. Participants will be assigned to either the study device or the standard dressing during their regular NHS podiatry clinic visits. The primary outcomes include complete wound healing at 12 weeks and the percentage reduction in wound area at the same time point. The study will be conducted in three diabetic foot clinics within NHS Lanarkshire under an open-label, comparative design.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for diabetic foot ulcers, potentially leading to faster healing and improved patient outcomes.
How similar studies have gone: While this approach is comparative, similar studies evaluating advanced wound dressings have shown promising results in improving healing outcomes for diabetic foot ulcers.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male or female, aged ≥18 years old with a diagnosis of type 1 or type 2 diabetes. * New presentation for treatment of a neuropathic, ischaemic or neuro- ischaemic non- infected DFU * Subjects must be able to follow verbal and written instructions in English * Subjects must have full mental capacity and able to give written informed consent to participation in the trial including medical photography for the purposes of the clinical trial or clinical care. * DFU is \>10mm2 and \<100mm2 Exclusion Criteria: * Known allergy/hypersensitivity to any ingredient contained in the Keneric healthcare RTD Wound Dressing * Participants who will have problems following the protocol, including the offloading system, provided as standard of care, to wear on a daily basis * Suspected malignancy in the wound * Critical limb ischaemia * Pregnant or breastfeeding females * Women of childbearing potential and not using a medically accepted form of contraception when sexually active.
Where it's running
-
NHS Lanarkshire
Airdrie, North Lanarkshire, United Kingdom Recruiting -
NHS Lothian
Livingston, West Lothian, United Kingdom Recruiting
Study contacts
- Principal investigator: Kaye McIntyre, MsC — NHS Lanarkshire
- Study coordinator: Duncan Stang, MChS
- Email: duncan.stang@lanarkshire.scot.nhs.uk
- Phone: 07554333493
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using stem cells from fat to treat diabetic foot ulcers
This study is testing if using stem cells from fat, along with a special blood product, can help heal chronic foot ulcers in people with diabetes.
-
BIOxHEAL plus standard care for nonhealing diabetic foot ulcers
A multicenter study tests whether applying BIOxHEAL, a placental-derived biologic, to stubborn diabetic foot ulcers helps more people heal when added to standard wound care.
-
Calcaneal Bone Marrow Cells in Foot/Ankle Surgery Patients
This observational study tests whether routine preoperative blood tests relate to the quality and behavior of mesenchymal stem cells from calcaneal bone marrow in adults undergoing foot or ankle surgery.
-
L-Carnitine as an add-on for healing diabetic foot ulcers
This study tests whether taking L-Carnitine helps wound healing in adults with diabetic foot ulcers, alongside standard diabetes and wound care.
-
THERAVEX Tissue Care Spray Plus for Healing of Skin Wounds and Ulcers
This observational review tests whether THERAVEX Tissue Care Spray Plus, used with standard wound care, helps heal various skin wounds and chronic ulcers in adults.
-
Pulsating electromagnetic field therapy for diabetic foot ulcers
This trial tests whether a PEMF device called CRAD ULCER X-01 helps heal chronic diabetic foot ulcers when added to standard wound care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.